Facioscapulohumeral Muscular Dystrophy
Showing 1 - 25 of 2,412
FSHD Trial (MSOT Acuity Echo)
Not yet recruiting
- FSHD
- MSOT Acuity Echo
- (no location specified)
Jun 5, 2023
FSHD, FSHD1, FSHD2 Trial (AOC 1020, Placebo)
Not yet recruiting
- FSHD
- +26 more
- AOC 1020
- Placebo
- (no location specified)
Feb 27, 2023
Facio-Scapulo-Humeral Dystrophy Trial (ARO-DUX4 for Injection, Placebo)
Not yet recruiting
- Facio-Scapulo-Humeral Dystrophy
- ARO-DUX4 for Injection
- Placebo
- (no location specified)
Nov 13, 2023
Facioscapulohumeral Muscular Dystrophy (FSHD) Trial (Placebo, RO7204239)
Recruiting
- Facioscapulohumeral Muscular Dystrophy (FSHD)
- Placebo
- RO7204239
-
København Ø, DenmarkRigshospitalet; Klinik for Nerve- og Muskelsygdomme
Feb 2, 2023
Type 1 Facioscapulohumeral Muscular Dystrophy Trial in Lille, Paris, Nice (Remote monitoring program)
Not yet recruiting
- Type 1 Facioscapulohumeral Muscular Dystrophy
- Remote monitoring program
-
Lille, Hauts De France, France
- +2 more
Mar 31, 2023
Unraveling Metabolic Involvement in Facioscapulohumeral
Not yet recruiting
- Facioscapulohumeral Muscular Dystrophy
- metabolomic on plasma sample
- (no location specified)
Oct 11, 2023
FSHD Molecular Characterization
Recruiting
- Facio-Scapulo-Humeral Dystrophy
-
Columbus, OhioThe Abigail Wexner Research Institute at Nationwide Children's H
Oct 20, 2023
pwFSHD (Patient With Facioscapulohumeral Muscular Dystrophy)
Completed
- Facio-Scapulo-Humeral Dystrophy
-
Istanbul, TurkeyIstanbul University-Cerrahpaşa
Nov 7, 2022
Myotonic Dystrophy and Facioscapulohumeral Muscular Dystrophy
Recruiting
- Myotonic Dystrophy
- +8 more
-
Rochester, New YorkUniversity of Rochester Medical Center, Department of Neurology
Jan 3, 2022
Facioscapulohumeral Muscular Dystrophy Type 2 Trial in France, Italy, Spain (Validation of new COMs for FSHD2 patients)
Recruiting
- Facioscapulohumeral Muscular Dystrophy Type 2
- Validation of new COMs for FSHD2 patients
-
Nice, Alpes M, France
- +5 more
Oct 6, 2023
Shoulder Instability in FSHD
Completed
- Shoulder Pain
- +4 more
- 3D movement analysis with surface electromyography and ultrasound
-
Oswestry, Gobowen, United KingdomRobert Jones & Agnes Hunt Orthopaedic Hospital
Jan 31, 2023
Facioscapulohumeral Muscular Dystrophy Trial in Rochester (Testosterone Enanthate, Somatropin)
Completed
- Facioscapulohumeral Muscular Dystrophy
- Testosterone Enanthate
- Somatropin
-
Rochester, New YorkUniversity of Rochester
Jun 7, 2022
Facioscapulohumeral Muscular Dystrophy Trial in Nice (Validation of new COMs for non ambulant FSHD patients)
Not yet recruiting
- Facioscapulohumeral Muscular Dystrophy
- Validation of new COMs for non ambulant FSHD patients
-
Nice, Alpes Maritimes, FranceCHU de Nice
Jul 11, 2022
A Registered Cohort Study on FSHD1
Recruiting
- Facioscapulohumeral Muscular Dystrophy Type 1 (FSHD1)
-
Fuzhou, Fujian, ChinaFirst Affiliated Hospital of Fujian Medical University
Jan 7, 2022
Muscular Dystrophy, Facioscapulohumeral Trial in Leiden (CHDR Monitoring Remotely (MORE), Withings Steel HR, Withings Body+
Completed
- Muscular Dystrophy, Facioscapulohumeral
- CHDR Monitoring Remotely (MORE)
- +3 more
-
Leiden, Zuid Holland, NetherlandsCentre for Human Drug Research
Mar 8, 2022
Duchenne Muscular Dystrophy, Fascioscapulohumeral Muscular Dystrophy Trial in Liège (ActiMyo)
Recruiting
- Duchenne Muscular Dystrophy
- Fascioscapulohumeral Muscular Dystrophy
- ActiMyo
-
Liège, BelgiumCHR de la Citadelle
Aug 1, 2023
Facioscapulohumeral Muscular Dystrophy (FSHD) Trial in Worldwide (Losmapimod, Placebo oral tablet)
Recruiting
- Facioscapulohumeral Muscular Dystrophy (FSHD)
- Losmapimod
- Placebo oral tablet
-
Irvine, California
- +31 more
Jul 28, 2022
Facioscapulohumeral Muscular Dystrophy (FSHD) Trial in Worldwide (Losmapimod, Placebo oral tablet)
Completed
- Facioscapulohumeral Muscular Dystrophy (FSHD)
- Losmapimod
- Placebo oral tablet
-
Irvine, California
- +16 more
Feb 8, 2022
FSHD1, FSHD2 Trial in Roma (Diaphragmatic ultrasound)
Recruiting
- FSHD1
- FSHD2
- Diaphragmatic ultrasound
-
Roma, ItalyFondazione Policlinico Gemelli IRCCS
Oct 5, 2023
Facioscapulohumeral Muscular Dystrophy, Charcot-Marie-Tooth Disease Trial in Canada, Spain, United States (ACE-083)
Terminated
- Facioscapulohumeral Muscular Dystrophy
- Charcot-Marie-Tooth Disease
-
Orange, California
- +23 more
Sep 13, 2022
The FBIndex - A Feasibility Study
Not yet recruiting
- Inclusion Body Myositis
- +5 more
- The risk of falls
- (no location specified)
May 26, 2023
Muscular Dystrophy, Facioscapulohumeral Trial in Lille, Paris, Nice (Validation of new COA for FSHD patients)
Recruiting
- Muscular Dystrophy
- Facioscapulohumeral
- Validation of new COA for FSHD patients
-
Lille, Hauts De France, France
- +2 more
Jan 23, 2023
Facioscapulohumeral Muscular Dystrophy Trial in Newcastle Upon Tyne (Patient Registry)
Unknown status
- Facioscapulohumeral Muscular Dystrophy
- Patient Registry
-
Newcastle Upon Tyne, United KingdomJohn Walton Muscular Dystrophy Research Centre
Jan 7, 2021
Biomarker Development for Muscular Dystrophies
Recruiting
- Myotonic Dystrophy
- +3 more
-
Boston, Massachusetts
- +4 more
Aug 20, 2021
Readiness to Solve Barriers to Drug Development in FSHD
Active, not recruiting
- Facioscapulohumeral Muscular Dystrophy
- FSHD-specific functional rating scale
- Electrical Impedance Myography
-
Los Angeles, California
- +7 more
Sep 27, 2021